Latest Tamoxifen Stories
Five Scientific Abstracts Presented at San Antonio Breast Cancer Symposium Demonstrate Benefit of VolparaDensity SAN ANTONIO (PRWEB) December 23, 2014
HOUSTON, July 23, 2014 /PRNewswire-USNewswire/ -- V.
New results from the National Health and Wellness Survey show non-adherence is associated with greater work and activity impairment. New York, NY (PRWEB) June
New Data Presented at ASCO® Annual Meeting Suggest that Genomic Health's Oncotype DX Test May Help Identify Patients That Have the Greatest Opportunity to Benefit from Extended Hormonal Therapy
Women who took clomiphene citrate (brand name Clomid) or gonadotropins as a part of fertility treatment did not experience an increased risk for breast cancer over 30 years of follow-up, compared with women who were not treated with these medications.
Joins Renowned Academic Scientists Charles Sawyers, Jose Baselga and Ronald Evans SAN DIEGO, April 3, 2014 /PRNewswire/ -- Seragon Pharmaceuticals Inc., a clinical-stage biotechnology
Dartmouth researchers at its Norris Cotton Cancer Center have compiled a review of the role that information gathered through genetic testing plays in the diagnosis and treatment of breast cancer.
MIAMI and NEW YORK, March 25, 2014 /PRNewswire/ -- Noven Pharmaceuticals, Inc. today announced the U.S. Patent and Trademark Office has issued U.S. Patent No.
SAN DIEGO, March 24, 2014 /PRNewswire/ -- Seragon Pharmaceuticals Inc., a clinical-stage biotechnology company focused on the development of drugs for hormone-driven cancers, today announced
Tamoxifen, a drug currently used to treat breast cancer, also kills a fungus that causes a deadly brain infection in immunocompromised patients.